A carregar...
Helicobacter pylori treatment in Turkey: Current status and rational treatment options
According to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5%. After FDA approval in 1995, many countries have used standard triple therapy (proton pump inhibitor 40 mg b.i.d clarithromycin 500 mg b.i.d and amoxicillin 1 gr b.i.d) for Helicobacter pylori treatment. In the b...
Na minha lista:
| Publicado no: | North Clin Istanb |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kare Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103748/ https://ncbi.nlm.nih.gov/pubmed/32232212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/nci.2019.62558 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|